Overview

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Glimepiride
Glucagon-Like Peptide 1
Metformin
Pioglitazone
rGLP-1 protein